<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220813055677N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-08</date_registration>
      <primary_sponsor>Bojnourd University of Medical Sciences</primary_sponsor>
      <public_title>The method of progressive muscle relaxation on the level of anxiety and vital signs of the elderly</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of progressive muscle relaxation on the level of anxiety and vital signs of hospitalized elderly</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>76</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65274</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: In this study, the Block Randomization method with blocks of 4 to 6 will be used. We will use Excel software and function (rand) to prepare random sequences. A specific numerical code will be assigned to each of the randomly generated sequences. When each individual enters the study, the group to which the individual belongs will be announced by contacting the epidemiologist of the study. The names and surnames of the patients along with the code created for them and the type of intervention received are registered and kept by the epidemiologist of the study who has the random chain, Blinding description: This study is one-sided blind in that the research assistant who is responsible for completing the questionnaires and measuring vital signs is unaware of the group to which the patient belongs.
This research is a one-way blinded randomized clinical trial study on the elderly hospitalized in Rasoul Akram Hospital, in such a way that after receiving the code of ethics and registration on the IRCT website and receiving the registration code at the clinical trial center, we will start recruiting patients. did Individuals after obtaining written informed consent from the patients which is in Appendix 5 (it should be noted that patients must sign two consent forms, one of which must be given to the researcher and the other to the patients) and after meeting the entry and non-entry criteria. , will enter the study and after receiving the initial information by the researcher's assistant, the people will be randomly and completely hidden and blinded as described above, placed in one or two intervention and control groups. The information of these people will be collected in CRF (Clinical Report Forms) which is in Appendix 6. The participants were divided into two intervention and control groups, the control group at 10-11 in the morning and 17-18 in the evening on two occasions for 3 consecutive days with an interval of 20 minutes, the vital signs (blood pressure, heart rate, respiration) are controlled and recorded in 24 4 shifts (three days in total 12 times) will be controlled and recorded by the researcher's assistant and at first the study vans will complete the existing questionnaire. It should be noted that the questionnaires are completed by the participants themselves in the study with them, but if they are unable to complete them with the help of the researcher, it will be completed in the form of an interview.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Investigating the effect of progressive muscle relaxation on the level of anxiety and vital signs of hospitalized elderly.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The control group will be monitored and recorded vital signs (blood pressure, heart rate, breathing) at 10-11 am and 17-18 pm on two occasions for 3 consecutive days at 20 minutes intervals. In 24 hours, 4 times (three days in total 12 times) are controlled and recorded by the assistant of the researcher and he completed the existing questionnaire at the beginning and end of the study. It should be noted that the questionnaires are completed by the study participants themselves or with them, but if they are unable to complete it with the help of the researcher, it is completed in the form of an interview. Blood, caffeinated drinks, feeling of elimination, consumption of heavy meals) and with a digital sphygmomanometer in a semi-sitting position, blood pressure of the patients from the right hand, heart rate by a pulse oximeter device (Beaver model) by the help of the researcher who has been trained by the researcher. And the correctness of the work of the researcher's assistant and the devices used and the method of measurement by him have been ensured and controlled and tested, and no intervention was done in these people. In the intervention group, the technique was performed on the patient's bed for 3 consecutive days in such a way that step by step along with the researcher, he was first taught step by step relaxation by progressive muscle relaxation method and he was asked to relax each of his muscles. Contract for 5 seconds. then release it for 10 seconds, in this way, first for the right hand and right forearm, right arm, left hand and forearm, left arm, forehead, eyes and cheeks, mouth and chin, neck, shoulders, shoulder girdle and the back of the neck, chest and abdomen, hips, right leg thigh, right leg leg, left thigh leg, left leg leg, then be completely relaxed and do deep tennis for 2 minutes in relaxation and relaxation and repeat this process twice a day. And from the second day of hospitalization (according to the approval of the attending physician), they were allowed to do relaxation exercises. Before performing the technique, all the additional equipment of the patient, such as watches, bracelets, rings, and fittings, and all equipment that could be separated, were separated from the patient and placed next to the patient. The patient is in a semi-sitting position with an angle of 30 degrees, according to the conditions of the inpatient department, this case is available for all subjects of the study. This technique is performed for the patient at 10-11 in the morning and 17-18 in the evening for 3 consecutive days for 20 minutes each time. After performing the technique, the vital signs (blood pressure, heart rate, breathing) are controlled and recorded by the assistant of the researcher after 20 minutes. In 24 hours, 4 times (three days in total 12 times) before and after the implementation of the technique, the patients' vital signs are monitored and recorded. Intervention 2: Control group: Individual characteristics questionnaire at the beginning of the study, anxiety questionnaire at the beginning of the study vans will be completed. Vital signs will be measured every day between 10-11 in the morning and 17-18 in the evening on two occasions with an interval of 20 minutes for 3 consecutive days by the researcher's assistant and recorded in the relevant checklist.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
In this study, all clinical and demographic information is coded in SPSS software for sharing.

When:
The access period starts 6 months after the publication of the results

To whom:
Doctors and nurses working in academic institutions related to medical sciences

Conditions:
Use of this research data will be permitted in meta-analysis studies

Where to obtain:
Contact: alisoheily70@gmail.com to receive the data

How to obtain:
The applicant will be contacted within 48 hours, and if the academic and employment records of the research environment are properly submitted, research data will be provided to the applicant upon confirmation of the identity of the originator.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fateme Khorashadizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing building, south side of Imam Ali Hospital, Shahriar St.</address>
        <city>Bojnurd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>94176-96786</zip>
        <telephone>009858332297096</telephone>
        <email>khorashadizadehf891@gmail.com</email>
        <affiliation>Bojnourd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fateme Khorashadizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing building, south side of Imam Ali Hospital, Shahriar St.</address>
        <city>Bojnurd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>94176-96786</zip>
        <telephone>009858332297296</telephone>
        <email>khorashadizadehf891@gmail.com</email>
        <affiliation>Bojnourd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 60 years and above
Having at least mild anxiety upon entering the study
Consent of the individual to participate in the study
Absence of unstable chronic diseases
Absence of neurological defects such as (stroke, Parkinson's disease and paralysis)
Not taking anti-anxiety drugs
Absence of limiting musculoskeletal disorders
Absence of severe congenital defects (vision, hearing and mental disorders, etc.)
People who have not participated in similar research.
Doctor's approval to participate in the study and no other medical restrictions
Absence of previously known mental disorder</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unstable chronic diseases
Neurological defects such as (stroke, Parkinson's disease and paralysis)
Taking anti-anxiety drugs
Existence of restrictive musculoskeletal disorders
Existence of severe congenital defects (vision, hearing and mental disorders, etc.)
Participation in similar research
Users of anti-anxiety drugs before hospitalization
Hospitalization due to complementary treatments and surgery
Disinterested in participating in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The control group will be monitored and recorded vital signs (blood pressure, heart rate, breathing) at 10-11 am and 17-18 pm on two occasions for 3 consecutive days at 20 minutes intervals. In 24 hours, 4 times (three days in total 12 times) are controlled and recorded by the assistant of the researcher and he completed the existing questionnaire at the beginning and end of the study. It should be noted that the questionnaires are completed by the study participants themselves or with them, but if they are unable to complete it with the help of the researcher, it is completed in the form of an interview. Blood, caffeinated drinks, feeling of elimination, consumption of heavy meals) and with a digital sphygmomanometer in a semi-sitting position, blood pressure of the patients from the right hand, heart rate by a pulse oximeter device (Beaver model) by the help of the researcher who has been trained by the researcher. And the correctness of the work of the researcher's assistant and the devices used and the method of measurement by him have been ensured and controlled and tested, and no intervention was done in these people. In the intervention group, the technique was performed on the patient's bed for 3 consecutive days in such a way that step by step along with the researcher, he was first taught step by step relaxation by progressive muscle relaxation method and he was asked to relax each of his muscles. Contract for 5 seconds. then release it for 10 seconds, in this way, first for the right hand and right forearm, right arm, left hand and forearm, left arm, forehead, eyes and cheeks, mouth and chin, neck, shoulders, shoulder girdle and the back of the neck, chest and abdomen, hips, right leg thigh, right leg leg, left thigh leg, left leg leg, then be completely relaxed and do deep tennis for 2 minutes in relaxation and relaxation and repeat this process twice a day. And from the second day of hospitalization (according to the approval of the attending physician), they were allowed to do relaxation exercises. Before performing the technique, all the additional equipment of the patient, such as watches, bracelets, rings, and fittings, and all equipment that could be separated, were separated from the patient and placed next to the patient. The patient is in a semi-sitting position with an angle of 30 degrees, according to the conditions of the inpatient department, this case is available for all subjects of the study. This technique is performed for the patient at 10-11 in the morning and 17-18 in the evening for 3 consecutive days for 20 minutes each time. After performing the technique, the vital signs (blood pressure, heart rate, breathing) are controlled and recorded by the assistant of the researcher after 20 minutes. In 24 hours, 4 times (three days in total 12 times) before and after the implementation of the technique, the patients' vital signs are monitored and recorded.</i_keyword>
      <i_keyword>Control group: Individual characteristics questionnaire at the beginning of the study, anxiety questionnaire at the beginning of the study vans will be completed. Vital signs will be measured every day between 10-11 in the morning and 17-18 in the evening on two occasions with an interval of 20 minutes for 3 consecutive days by the researcher's assistant and recorded in the relevant checklist.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety score. Timepoint: At the beginning and end of the study. Method of measurement: Beck's anxiety questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Blood pressure. Timepoint: Four times a day for three days before and 20 minutes after the intervention. Method of measurement: KD 595 digital easy life blood pressure monitor.</sec_outcome>
      <sec_outcome>Breathing rate. Timepoint: Four times a day for three days before and 20 minutes after the intervention. Method of measurement: It is counted by the research assistant in one minute.</sec_outcome>
      <sec_outcome>Number of heartbeats. Timepoint: Four times a day for three days before and 20 minutes after the intervention. Method of measurement: Measurement with pulse oximeter.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bojnourd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-06</approval_date>
        <contact_name>Ethics Committee of North Khorasan University of Medical Sciences</contact_name>
        <contact_address>Faculty of Nursing building, south side of Imam Ali Hospital, Shahriar St Bojnurd North Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
